Post-marketing surveillance of overnight orthokeratology: 3-year follow-up study in Japan

被引：0
|
作者：
Hiraoka, Takahiro [1 ]
Okamoto, Yoshifumi [1 ]
Okamoto, Fumiki [1 ]
Oshika, Tetsuro [1 ]
机构：
[1] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6088
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Post-marketing surveillance of celecoxib safety: a 12-year follow-up study in France
    Chenaf, C.
    Andorra, A.
    Parry, E.
    Authier, N.
    Zenut, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 74 - 74
  • [2] The Follow-Up Activity in Vaccine Post-Marketing Surveillance in Italy
    Felicetti, P.
    Trotta, F.
    Bonetto, C.
    Ferrazin, F.
    Santuccio, C.
    [J]. DRUG SAFETY, 2012, 35 (10) : 911 - 911
  • [3] Post-marketing surveillance of Arcoxia® (etoricoxib) safety: a 6.5-year follow-up study in France
    Chenaf, C.
    Andorra, A.
    Fournier-Choma, C.
    Authier, N.
    Zenut, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 69 - 69
  • [4] Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up
    Yagi, Nobuyuki
    Okada, Kenya
    Sudo, Yohei
    Itoh, Hiromichi
    Yoshida, Hisao
    Kuroda, Tatsuhiko
    [J]. SAGE OPEN MEDICINE, 2014, 2 : 1 - 27
  • [5] Post-marketing surveillance of ROACTEMRA® (tocilizumab) safety: a six-year follow-up in France
    Chenaf, C.
    Andorra, A.
    Parry, E.
    Faidi, S.
    Laudet, M.
    Authier, N.
    Zenut, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 50 - 50
  • [6] Post-marketing surveillance of Arcoxia® (etoricoxib) safety: a 2-year follow-up in France
    Chenaf, C.
    Perrazi, A.
    Batz, A.
    Eschalier, A.
    Zenut, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 105 - 106
  • [7] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Stanley Cohen
    Jeffrey R. Curtis
    Ryan DeMasi
    Yan Chen
    Haiyun Fan
    Arif Soonasra
    Roy Fleischmann
    [J]. Rheumatology and Therapy, 2018, 5 : 283 - 291
  • [8] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Cohen, Stanley
    Curtis, Jeffrey R.
    DeMasi, Ryan
    Chen, Yan
    Fan, Haiyun
    Soonasra, Arif
    Fleischmann, Roy
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 283 - 291
  • [9] POST-MARKETING SURVEILLANCE OF OFLOXACIN IN JAPAN
    YAMADA, A
    NAKAMURA, S
    TAKAHASHI, K
    SAWADA, M
    OKADA, S
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1409 - S1409
  • [10] Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
    Ikezoe, Takayuki
    Noji, Hideyoshi
    Ueda, Yasutaka
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Usuki, Kensuke
    Matsuda, Takahisa
    Akiyama, Hirozumi
    Shimono, Akihiko
    Yonemura, Yuji
    Kawaguchi, Tatsuya
    Chiba, Shigeru
    Kanakura, Yuzuru
    Nishimura, Jun-Ichi
    Ninomiya, Haruhiko
    Obara, Naoshi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 470 - 480
12345